Array Biopharma Inc

Ambrosia, like Pfizer, is optimistic about the direction of oral small molecules, but whether it can surpass the front runners is something that still needs more time to verify

原文始发于微信公众号（药时代）：数十家跨国药企围猎NTRK激酶抑制剂！谁是王者？ 友情提醒 千人盛会本周三、四将在张江博雅酒店隆重召开。我们怀着激动的心情恭候已报名的嘉宾按时出席，…